CVRx, Inc. (CVRX)
3.15
+0.31
(+10.92%)
USD |
NASDAQ |
Aug 24, 16:00
3.15
0.00 (0.00%)
After-Hours: 20:00
CVRx Debt to Equity Ratio : 2.976 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.976 |
| March 31, 2026 | 2.040 |
| December 31, 2025 | 1.284 |
| September 30, 2025 | 1.051 |
| June 30, 2025 | 0.8724 |
| March 31, 2025 | 0.727 |
| December 31, 2024 | 0.7098 |
| September 30, 2024 | 0.7738 |
| June 30, 2024 | 0.5537 |
| March 31, 2024 | 0.4618 |
| December 31, 2023 | 0.4031 |
| September 30, 2023 | 0.1857 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.171 |
| March 31, 2023 | 0.1456 |
| December 31, 2022 | 0.0649 |
| September 30, 2022 | 0.0033 |
| June 30, 2022 | 0.0036 |
| March 31, 2022 | 0.0037 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.1251 |
| June 30, 2021 | -1.096 |
| March 31, 2021 | -1.158 |
| December 31, 2020 | -1.191 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| NeuroPace, Inc. | 5.885 |
| Accuray, Inc. | 4.410 |
| Orthofix Medical, Inc. | 0.6102 |
| ResMed, Inc. | 0.1254 |
| Rockwell Medical, Inc. | 0.3971 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 92.28M |
| Total Liabilities (Quarterly) | 72.33M |
| Shareholders Equity (Quarterly) | 19.95M |
| Current Ratio | 8.045 |
| Net Debt Paydown Yield | -1.31% |